Empirical therapy of bloodstream infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae

• Published in: Zhong hua yi xue za zhi Vol. 96; no. 26; p. 2076
• Main Authors: Tang, C Q, Li, J Q, Xia, Z F, Wang, H, Lü, K Y, Xiao, S C, Deng, A M, Huang, Y
• Format: Journal Article
• Language: Chinese
• Published: China 12.07.2016
• Subjects: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitalization; Hospitals; Humans

To compare the clinical outcomes and costs associated with carbapenems and β-lactam/β-lactamase inhibitor combinations (BLBLIs) for the empirical treatment of patients with extended-spectrum β-lactamase (ESBL)-positive Enterobacteriaceae bloodstream infections (BSIs). The medical records of individu...